ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under SEB (PIT) Regulations.22-02-2022
22-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under Regulation 7(2) of SEBI (PIT) Regulations, 201516-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under Regulation 7(2) of SEBI (PIT) Regulations, 2015.16-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Intimation of Resignation of Mr. Dhanraj Dagar as the Company Secretary and Compliance officer of the Company.15-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under Regulation 7(2) of SEBI (PIT) Regulations, 201514-02-2022
Zydus Pharmaceuticals (USA) Inc gets final USFDA approval to market Roflumilast tablets
Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug exclusivity, Cadlia Healthcare said in a regulatory filing.14-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Investors' Call held on February 2, 2022.07-02-2022
Buy Zydus Wellness; target of Rs 2,505: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy on the stock with a revised price target (PT) of Rs. 2,505 in its research report dated February 02, 2022.04-02-2022
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of consolidated financial results of the Company for the quarter and nine months ended on December 31, 2021.03-02-2022
Zydus Wellness Q3 net profit jumps over 1,200% YoY to Rs 23 crore
The company reported consolidated net sales of Rs 384.9 crore, a growth of 2.3%; Five key brands maintained leadership positions in respective categories02-02-2022